Cite
MLA Citation
R.G. Langley et al.. “Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial.” British journal of dermatology, vol. 178, 2018, pp. 114–123. http://access.bl.uk/ark:/81055/vdc_100172215933.0x00005b